The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

News of the Federation of Anesthesiologists and Resuscitators (FAR)

Read: 980 times

To cite this article:

News of the Federation of Anesthesiologists and Resuscitators (FAR). Russian Journal of Anesthesiology and Reanimatology. 2023;(5):95‑96. (In Russ.)

References:

  1. Merz TM, Regli B, Rothen HU, Felleiter P. Propofol infusion syndrome: a fatal case at a low infusion rate. Anesthesia and Analgesia. 2006;103(4):1050. https://doi.org/10.1213/01.ane.0000239080.82501.c7
  2. Chukwuemeka A, Ko R, Ralph-Edwards A. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anesthesia and Intensive Care. 2006;34(5):651-655.  https://doi.org/10.1177/0310057X0603400503
  3. Roberts RJ, Barletta JF, Fong JJ, Schumaker G, Kuper PJ, Papadopoulos S, Yogaratnam D, Kendall E, Xamplas R, Gerlach AT, Szumita PM, Anger KE, Arpino PA, Voils SA, Grgurich P, Ruthazer R, Devlin JW.Incidence of propofol-related infu- sion syndrome in critically ill adults: A prospective, multicenter study. Critical Care. 2009;13(5):169.  https://doi.org/10.1186/cc8145
  4. Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. A double-blind, randomized comparison of i.v.lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology. 2001;95(2):286-298.  https://doi.org/10.1097/00000542-200108000-00007
  5. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Critical Care Medicine. 1998;26(5):947-956.  https://doi.org/10.1097/00003246-199805000-00034
  6. Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Population pharmacodynamics modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients. European Journal of Clinical Pharmacology. 2006;62(3):185-194.  https://doi.org/10.1007/s00228-005-0085-8
  7. Swart EL, de Jongh J, Zuideveld KP, Danhof M, Thijs LG, Strack van Schijndel RJ. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous veno-venous hemofiltration. American Journal of Kidney Diseases. 2005;45(2):360-371.  https://doi.org/10.1053/j.ajkd.2004.09.004
  8. Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. British Journal of Clinical Pharmacology. 2004;57(2):145.  https://doi.org/10.1046/j.1365-2125.2003.01957.x
  9. Ariano RE, Kassum DA, Aronson KJ. Comparison of sedative recovery time after midazolam versus diazepam administration. Critical Care Medicine. 1994;22(9):1492-1496. https://doi.org/10.1097/00003246-199409000-00022
  10. Garcia R, Salluh JIF, Andrade TR, Farah D, da Silva PSL, Bastos DF, Fonseca MCM. A systematic review and meta-analysis of propofol versus midazolam sedation in adult intensive care (ICU) patients. Journal of Critical Care. 2021;64:91-99.  https://doi.org/10.1016/j.jcrc.2021.04.001
  11. Buckley MS, Smithburger PL, Wong A, Fraser GL, Reade MC, Klein-Fedyshin M. Dexmedetomidine for facilitating mechanical ventilation extubation in difficult-to-wean ICU patients: systematic review and meta-analysis of clinical trials. Journal of Intensive Care Medicine. 2020;6:885066620937673. https://doi.org/10.1177/0885066620937673
  12. Chen P, Jiang J, Zhang Y, Li G, Qiu Z, Levy MM, Hu B. Effect of dexmedetomidine on duration of mechanical ventilation in septic patients: a systematic review and meta-analysis. BMC Pulmonary Medicine. 2020;20(1):42.  https://doi.org/10.1186/s12890-020-1065-6
  13. Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A, Jackson JC, Hoskins AS, Pun BT, Orun OM, Raman R, Stollings JL, Kiehl AL, Duprey MS, Bui LN, O’Neal HR Jr, Snyder A, Gropper MA, Guntupalli KK, Stashenko GJ, Patel MB, Brummel NE, Girard TD, Dittus RS, Bernard GR, Ely EW, Pandharipande PP; MENDS2 Study Investigators. Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis. New England Journal of Medicine. 2021;384(15):1424-1436. https://doi.org/10.1056/NEJMoa2024922
  14. Heybati K, Zhou F, Ali S, Deng J, Mohananey D, Villablanca P, Ramakrishna H. Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials. British Journal of Anaesthesia. 2022;129(4):515-526.  https://doi.org/10.1016/j.bja.2022.06.020
  15. Patel SB, Kress JP. Sedation and Analgesia in the Mechanically Ventilated Patient. American journal of respiratory and Critical Care Medicine. 2012;185(5):486-497.  https://doi.org/10.1164/rccm.201102-0273CI
  16. Zhou Y, Jin X, Kang Y, Liang G, Liu T, Deng N. Midazolam and propofol used alone or sequentially for long-term sedation in critically ill, mechanically ventilated patients: A prospective, randomized study. Critical Care. 2014;18(3):R122. https://doi.org/10.1186/cc13922
  17. Casault C, Soo A, Lee CH. Sedation strategy and ICU delirium: a multicentre, population-based propensity score-matched cohort study. BMJ Open. 2021;11:e045087. https://doi.org/10.1136/bmjopen-2020-045087
  18. Huey-Ling L, Chun-Che S, Jen-Jen T, Shau-Ting L, Hsing-I C. Comparison of the effect of protocol-directed sedation with propofol vs. Midazolam by nurses in intensive care: Efficacy, haemodynamic stability and patient satisfaction. Journal of Clinical Nursing. 2008;17(11):1510-1517. https://doi.org/10.1111/j.1365-2702.2007.02128.x
  19. Mesnil M, Capdevila X, Bringuier S, Trine PO, Falquet Y, Charbit J, Roustan JP, Chanques G, Jaber S. Long-term sedation in intensive care unit: A randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Medicine. 2011;37(6):933-941.  https://doi.org/10.1007/s00134-011-2187-3
  20. Srivastava VK, Agrawal S, Kumar S, Mishra A, Sharma S, Kumar R. Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients. Journal of Clinical and Diagnostic Research. 2014;8:GC04GC07. https://doi.org/10.7860/JCDR/2014/8797.4817
  21. Kawazoe Y, Miyamoto K, Morimoto T, Yamamoto T, Fuke A, Hashimoto A, Koami H, Beppu S, Katayama Y, Itoh M, Ohta Y, Yamamura H; Dexmedetomidine for Sepsis in Intensive Care Unit Randomized Evaluation (DESIRE) Trial Investigators. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis a randomized clinical trial. JAMA. 2017;317(13):1321-1327. https://doi.org/10.1001/jama.2017.2088
  22. Reade MC, Eastwood GM, Bellomo R, Bailey M, Bersten A, Cheung B, Davies A, Delaney A, Ghosh A, van Haren F, Harley N, Knight D, McGuiness S, Mulder J, O’Donoghue S, Simpson N, Young P; DahLIA Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA. 2016;315(14):1460-1468. https://doi.org/10.1001/jama.2016.2707
  23. Farina N, Alaniz C. Reconsidering Dexmedetomidine for Sedation in the Critically Ill: Implications of the SPICE III Trial. Annals of Pharmacotherapy. 2020;54(5):504-508.  https://doi.org/10.1177/1060028019890672
  24. Møller MH, Alhazzani W, Lewis K, Belley-Cote E, Granholm A, Centofanti J, McIntyre WB, Spence J, Al Duhailib Z, Needham DM, Evans L, Reintam Blaser A, Pisani MA, D’Aragon F, Shankar-Hari M, Alshahrani M, Citerio G, Arora RC, Mehta S, Girard TD, Ranzani OT, Hammond N, Devlin JW, Shehabi Y, Pandharipande P, Ostermann M. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline. Intensive Care Medicine. 2022;48(7):801-810.  https://doi.org/10.1007/s00134-022-06660-x
  25. Mulkey MA, Everhart DE. Sedation selection to reduce delirium risk: Why dexmedetomidine may be a better choice. Journal of the American Association of Nurse Practitioners. 2020;33(4):266-270.  https://doi.org/10.1097/JXX.0000000000000364
  26. Nelson KM, Patel GP, Hammond DA. Effects from continuous infusions of dexmedetomidine and propofol on hemodynamic stability in critically ill adult patients with septic shock. Journal of Intensive Care Medicine. 2020:35(9):875-880.  https://doi.org/10.1177/0885066618802269
  27. Chang YF, Chao A, Shih PY, Hsu YC, Lee CT, Tien YW, Yeh YC, Chen LW; NTUH Center of Microcirculation Medical Research (NCMMR). Comparison of dexmedetomidine versus propofol on hemodynamics in surgical critically ill patients. The Journal of Surgical Research. 2018;228:194-200.  https://doi.org/10.1016/j.jss.2018.03.040
  28. Owusu KA, Kurczewski L, Armahizer MJ, Zichichi A, Maciel CB, Heavner MS. DEXmedetomidine compared to PROpofol in NEurocritical Care [DEXPRONE]: A multicenter retrospective evaluation of clinical utility and safety. Journal of Critical Care. 2020;60:79-83.  https://doi.org/10.1016/j.jcrc.2020.07.021
  29. Wang G, Niu J, Li Z, Lv H, Cai H. The efficacy and safety of dexmedetomidine in cardiac surgery patients: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0202620. https://doi.org/10.1371/journal.pone.0202620
  30. Lin Y, He B, Chen J, Wang Z. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis. Critical Care. 2012;16(5):R169. https://doi.org/10.1186/cc11646
  31. Brock L. Dexmedetomidine in Adult Patients in Cardiac Surgery Critical Care: An Evidence-Based Review. AACN Advanced Critical Care. 2019;30(3):259-268.  https://doi.org/10.4037/aacnacc2019888
  32. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50(3):206-217.  https://doi.org/10.1176/appi.psy.50.3.206
  33. Djaiani G, Silverton N, Fedorko L, Carroll J, Styra R, Rao V, Katznelson R. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology. 2016;124(2):362-368.  https://doi.org/10.1097/ALN.0000000000000951
  34. Smithburger PL, Patel MK. Pharmacologic Considerations Surrounding Sedation, Delirium, and Sleep in Critically Ill Adults: A Narrative Review. Journal of Pharmacy Practice. 2019;32(3):271-291.  https://doi.org/10.1177/0897190019840120
  35. Allam MG. Dexmedetomidine versus midazolam for sedation of critically ill patients on noninvasive mechanical ventilation. Ain-Shams Journal of Anaesthesiology. 2016;9(2):178-185.  https://doi.org/10.4103/1687-7934.179910
  36. Huang Z, Chen YS, Yang ZL, Liu JY. Dexmedetomidine versus midazolam for the sedation of patients with noninvasive ventilation failure. Internal Medicine. 2012;51(17):2299-2305. https://doi.org/10.2169/internalmedicine.51.7810
  37. Karim HM, Šarc I, Calandra C, Spadaro S, Mina B, Ciobanu LD, Gonçalves G, Caldeira V, Cabrita B, Perren A, Fiorentino G, Utku T, Piervincenzi E, El-Khatib M, Alpay N, Ferrari R, Abdelrahim ME, Saeed H, Madney YM, Harb HS, Vargas N, Demirkiran H, Bhakta P, Papadakos P, Gómez-Ríos MÁ, Abad A, Alqahtani JS, Hadda V, Singha SK, Esquinas AM. Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations. Indian Journal of Critical Care Medicine. 2022;26(8):938-948.  https://doi.org/10.5005/jp-journals-10071-23950
  38. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology. 2004;101(2):299-310.  https://doi.org/10.1097/00000542-200408000-00009
  39. Hellström J, Öwall A, Bergström J, Sackey PV. Cardiac outcome after sevoflurane versus propofol sedation following coronary bypass surgery: a pilot study. Acta Anaesthesiologica Scandinavica. 2011;55(4):460-467.  https://doi.org/10.1111/j.1399-6576.2011.02405.x
  40. Soro M, Gallego L, Silva V, Ballester MT, Lloréns J, Alvariño A, García-Perez ML, Pastor E, Aguilar G, Martí FJ, Carratala A, Belda FJ. Sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double- blind randomised study. European Journal of Anaesthesiology. 2012;29(12):561-569.  https://doi.org/10.1097/EJA.0b013e3283560aea
  41. Bellgardt M, Bomberg H, Herzog-Niescery J, Dasch B, Vogelsang H, Weber TP, Steinfort C, Uhl W, Wagenpfeil S, Volk T, Meiser A. Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients. European Journal of Anaesthesiology. 2015;32(1):6-13.  https://doi.org/10.1097/EJA.0000000000000252
  42. Soro M, Belda FJ, Badenes R, Alcantara MJ. Use of the AnaConDa (Anestesia Conserving Device) with sevoflurane in critical care patients. European Journal of Anaesthesiology. 2004;21(Suppl 32):708.  https://doi.org/10.1097/00003643-200406002-00631
  43. Jerath A, Beattie SW, Chandy T, Karski J, Djaiani G, Rao V, Yau T, Wasowicz M. Volatile-based short-term sedation in cardiac surgical patients: a prospective randomized controlled trial. Critical Care Medicine. 2015;43(5):1062-1069. https://doi.org/10.1097/CCM.0000000000000938
  44. Martin J, Heymann A, Bäsell K, Baron R, Biniek R, Bürkle H, Dall P, Dictus C, Eggers V, Eichler I, Engelmann L, Garten L, Hartl W, Haase U, Huth R, Kessler P, Kleinschmidt S, Koppert W, Kretz FJ, Laubenthal H, Marggraf G, Meiser A, Neugebauer E, Neuhaus U, Putensen C, Quintel M, Reske A, Roth B, Scholz J, Schröder S, Schreiter D, Schüttler J, Schwarzmann G, Stingele R, Tonner P, Tränkle P, Treede RD, Trupkovic T, Tryba M, Wappler F, Waydhas C, Spies C. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care — short version. German Medical Science. 2010;8:Doc02. https://doi.org/10.3205/000091
  45. Kim HY, Lee JE, Kim HY, Kim J. Volatile sedation in the intensive care unit:A systematic review and meta-analysis. Medicine. 2017;96(49):e8976. https://doi.org/10.1097/MD.0000000000008976
  46. Meiser A, Volk T, Wallenborn J, Guenther U, Becher T, Bracht H, Schwarzkopf K, Knafelj R, Faltlhauser A, Thal SC, Soukup J, Kellner P, Drüner M, Vogelsang H, Bellgardt M, Sackey P; Sedaconda study group. Inhaled isofurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial. The Lancet. Respiratory Medicine. 20219(11):1231-1240. https://doi.org/10.1016/S2213-2600(21)00323-4
  47. Blondonnet R, Balde A, Zhai R, Pereira B, Futier E, Bazin J-E, Use of volatile anesthetics for sedation in the ICU during the COVID-19 pandemic: A national survey in France (VOL’ICU 2 study). PLoS One. 2022;17(12):e0278090. https://doi.org/10.1371/journal.pone.0278090
  48. Fraser GL, Devlin JW, Worby CP, Alhazzani W, Barr J, Dasta JF, Kress JP, Davidson JE, Spencer FA. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Critical Care Medicine. 2013;41(9):30-38.  https://doi.org/10.1097/CCM.0b013e3182a16898
  49. Jung S, Na S, Kim HB, Joo HJ, Kim J. Inhalation sedation for postoperative patients in the intensive care unit: initial sevoflurane concentration and comparison of opioid use with propofol sedation. Acute Critical Care. 2020;35(3):197-204.  https://doi.org/10.4266/acc.2020.00213
  50. Jerath A, Slessarev M. The impact of the coronavirus pandemic on sedation in critical care: volatile anesthetics in the ICU. Current Opinion in Critical Care. 2023;29(1):14-18.  https://doi.org/10.1097/MCC.0000000000001011
  51. Burov NE. Ideas about the mechanism of anesthetic and therapeutic properties of xenon. Anesteziologiya i Reanimatologiya. 2011;2:58-62. (In Russ.).
  52. Stryapko NV, Sazontova TG, Potievskaya VI, Molchanov IV. Adaptive effect of repeated use of xenon. Obshchaya reanimatologiya. 2014;10(2):50-56. (In Russ.).
  53. Liu W, Liu Y, Chen H, Liu K, Tao H, Sun X. Xenon preconditioning: molecular mechanisms and biological effects. Medical Gas Research. 2013;3(1):3.  https://doi.org/10.1186/2045-9912-3-3
  54. Molchanov IV, Potievskaya VI, Pulina NN, Shebzukhova EKh. Treatment of patients with acute coronary syndrome by xenon inhalation. Doctor.Ru. 2012;10(78):35-40. (In Russ.).
  55. Lakhin RE, Andreenko AA, Vlasenko AV, Martynov DV, Lazarev VV, Ovezov AM, Gorbachev VI, Leiderman IN, Belkin AA, Fischer VV, Lomivorotov VV, Kuzkov VV, Shifman EM, Grigoriev EV, Popov AS, Magomedov MA, Yaroshetsky AI. Modified Delphic analysis of the provisions and quality criteria of methodological recommendations «Sedation of patients in departments of anesthesiology, intensive care and intensive care». Vestnik intensivnoj terapii im. A.I. Saltanova. 2023;(2):45-54. (In Russ.). https://doi.org/10.21320/1818-474X-2023-2-45-54
  56. Email Confirmation

    An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

    Email Confirmation

    We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.